Formulation & Evaluation Of Pantoprazole Enteric Coated Tablet For The Treatment Of Peptic Ulcer

Main Article Content

Sunil Sawant
Dr. Vijay Kumar Sharma
Dr. Swati Deshmukh

Abstract

The purpose of this study was to prepare Pantoprazole enteric coated modified release formulation by using various super disintegrates and by keeping optimum physical parameters like hardness, thickness, disintegration and weight variation of the tablets so as to control the disintegration of the tablets which ultimately gives effect on dissolution of tablets which is having direct impact on drug release. The uncoated tablets were further enteric coated by using dipping method. The enteric coated tablet were again evaluated for hardness, Thickness, Friability, Weight Variation and Drug Content Uniformity, in-vitro dissolution testing and stability study was performed for optimized batch and further anti-ulcer activity was also performed. The average hardness increased to 2.97 Kg/cm2, Average thickness also increased to 2.27 and average friability also decreased to 0.52% due to enteric coating. The Weight Variation was again under 5%. The Drug Content uniformity was found to be between 97-102%. In in-vitro dissolution testing, in initial 2 hours maximum drug release was of 2.10% in 0.1N hydrochloric acid and showed maximum of 92.45% drug release in phosphate buffer pH 6.8 over the period of total 12 hours for F8 batch. Therefore F8 batch was considered to be optimized batch and selected for anti-ulcer activity on animals. The study was conducted on 12 subjects and eleven subject showed maximum subjects revealed that the plasma drug concentration of test was quite similar to that of reference.

Downloads

Download data is not yet available.

Article Details

How to Cite
Sunil Sawant, Dr. Vijay Kumar Sharma, & Dr. Swati Deshmukh. (2024). Formulation & Evaluation Of Pantoprazole Enteric Coated Tablet For The Treatment Of Peptic Ulcer. Journal of Advanced Zoology, 44(S7), 1293–1307. https://doi.org/10.53555/jaz.v44iS7.3171
Section
Articles
Author Biographies

Sunil Sawant

Department of Pharmaceutical Sciences, Apex University, Jaipur, Rajasthan, India. 2.Siddhant College of Pharmacy, Sudumbare, Pune, Maharashtra

Dr. Vijay Kumar Sharma

Department of Pharmaceutical Sciences, Apex University, Jaipur, Rajasthan, India. 2.Siddhant College of Pharmacy, Sudumbare, Pune, Maharashtra

Dr. Swati Deshmukh

Department of Pharmaceutical Sciences, Apex University, Jaipur, Rajasthan, India. 2.Siddhant College of Pharmacy, Sudumbare, Pune, Maharashtra

References

Shin, J. M., & Sachs, G. (2008). Pharmacology of proton pump inhibitors. Current gastroenterology reports, 10(6), 528–534. https://doi.org/10.1007/s11894-008-0098-4.

Richard Jewell, Pantoprazole, Editor(s): S.J. Enna, David B. Bylund, x Pharm, The Comprehensive Pharmacology Reference,Elsevier,2007, Pages 1-5,ISBN 9780080552323,https://doi.org/10.1016/B978-008055232-3.62361-X.

Moreira Dias L. (2009). Pantoprazole: a proton pump inhibitor. Clinical drug investigation, 29 Suppl 2, 3–12. https://doi.org/10.2165/1153121-S0-000000000-00000.

Divakar Kanakagiri, Hari Omprakash, Kishore Kumar M, Vishwanadham Y. Formulation and Evaluation of Pantoprazole Delayed Release Tablets using Eudragit L30D55. Research J. Pharm. and Tech. 2017; 10(2): 421-425. doi: 10.5958/0974-360X.2017.00084.1

Gayatri D. Patil, Kaveri P. Tambe, Sangita P. Shirsat, Paresh A. Patil. Review on Enteric Coated Polymers. Res. J. Pharma. Dosage Forms and Tech.2021; 13(1):82-85. doi: 10.5958/0975-4377.2021.00015.X

Mejia, A., & Kraft, W. K. (2009). Acid peptic diseases: pharmacological approach to treatment. Expert review of clinical pharmacology, 2(3), 295–314. https://doi.org/10.1586/ecp.09.8

Ali Khan, M., & Howden, C. W. (2018). The Role of Proton Pump Inhibitors in the Management of Upper Gastrointestinal Disorders. Gastroenterology & hepatology, 14(3), 169–175.

Wen, H., Jung, H., & Li, X. (2015). Drug Delivery Approaches in Addressing Clinical Pharmacology-Related Issues: Opportunities and Challenges. The AAPS journal, 17(6), 1327–1340.

https://doi.org/10.1208/s12248-015-9814-9

National Center for Biotechnology Information (2023). PubChem Compound Summary for CID 4679, Pantoprazole. Retrieved September 12, 2023 from

https://pubchem.ncbi.nlm.nih.gov/compound/Pantoprazole.

Barnabas Wilson, Patel Pritesh Babubhai1 Moothandassery Sankarakutty Sajeev Josephine Leno Jenita1 S. R. Brahmani Priyadarshin. Sustained release enteric coated tablets of pantoprazole: Formulation, in vitro and in vivo evaluation. Acta Pharm. 63 (2013) 131–140.

Nair, A. B., Gupta, R., Kumria, R., Jacob, S., & Attimarad, M. (2010). Formulation and evaluation of enteric coated tablets of proton pump inhibitor. Journal of basic and clinical pharmacy, 1(4), 215–221.

Karan Arya, Shobit Singh, Raghvendra Sharma (2021). Formulation and Characterization of Pantoprazole Enteric Coated Multi Unit Pellet System. Der Pharmacia Lettre. 13(3): 32-36.

Balaji M., Ramyakrishna N., Hanumanaik M. (2020). Formulation Development and Characterization of Enteric Coated Tablets of Lansoprazole. Der Pharmacia Lettre, 12 (3): 22-38.

Mohammed Sarfaraz, Vijaya Gopalachar Joshi (2014). Development and characterization of enteric-coated salbutamol sulphate time release tablets. International Journal of Drug Delivery. 6, 64-74.